129 related articles for article (PubMed ID: 23071006)
1. Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors.
Robert MA; Lin Y; Bendjelloul M; Zeng Y; Dessolin S; Broussau S; Larochelle N; Nalbantoglu J; Massie B; Gilbert R
J Gene Med; 2012 Dec; 14(12):746-60. PubMed ID: 23071006
[TBL] [Abstract][Full Text] [Related]
2. Strong muscle-specific regulatory cassettes based on multiple copies of the human slow troponin I gene upstream enhancer.
Blain M; Zeng Y; Bendjelloul M; Hallauer PL; Kumar A; Hastings KE; Karpati G; Massie B; Gilbert R
Hum Gene Ther; 2010 Jan; 21(1):127-34. PubMed ID: 19719387
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.
Ngai SC; Rosli R; Nordin N; Veerakumarasivam A; Abdullah S
Gene; 2012 May; 498(2):231-6. PubMed ID: 22366305
[TBL] [Abstract][Full Text] [Related]
4. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors.
Shi CX; Hitt M; Ng P; Graham FL
Hum Gene Ther; 2002 Jan; 13(2):211-24. PubMed ID: 11812278
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
6. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
Shi CX; Graham FL; Hitt MM
J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
[TBL] [Abstract][Full Text] [Related]
7. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
8. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
9. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
10. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
Cao B; Bruder J; Kovesdi I; Huard J
Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
12. The combination of a synthetic promoter and a CMV promoter improves foreign gene expression efficiency in myocytes.
Jianwei D; Qianqian Z; Songcai L; Mingjun Z; Xiaohui R; Linlin H; Qingyan J; Yongliang Z
J Biotechnol; 2012 Apr; 158(3):91-6. PubMed ID: 22206980
[TBL] [Abstract][Full Text] [Related]
13. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
16. Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter.
Takayama K; Torashima T; Horiuchi H; Hirai H
Neurosci Lett; 2008 Sep; 443(1):7-11. PubMed ID: 18675313
[TBL] [Abstract][Full Text] [Related]
17. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer.
Larochelle N; Lochmüller H; Zhao J; Jani A; Hallauer P; Hastings KE; Massie B; Prescott S; Petrof BJ; Karpati G; Nalbantoglu J
Gene Ther; 1997 May; 4(5):465-72. PubMed ID: 9274724
[TBL] [Abstract][Full Text] [Related]
18. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
19. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
[TBL] [Abstract][Full Text] [Related]
20. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.
Sandig V; Löser P; Lieber A; Kay MA; Strauss M
Gene Ther; 1996 Nov; 3(11):1002-9. PubMed ID: 9044740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
